Chiesi Group

About Chiesi Group

Chiesi Group is a global pharmaceutical company with a strong commitment to research and development, focusing on innovative solutions for patients. Established in 1935, the company has grown significantly, now operating in over 30 countries worldwide. Chiesi is dedicated to improving the quality of life for patients through the development of high-quality medicines, particularly in the fields of respiratory, neonatology, and rare diseases.

The company’s mission is to create value for patients, healthcare professionals, and society by providing effective therapeutic solutions. Chiesi Group invests heavily in R&D, with a significant portion of its revenue allocated to discovering new treatments and improving existing ones. The company collaborates with various stakeholders, including academic institutions and healthcare providers, to foster innovation and enhance patient care.

Chiesi is also committed to sustainability and corporate social responsibility, striving to minimize its environmental impact while promoting health and well-being in the communities it serves. The company’s values are rooted in integrity, respect, and collaboration, guiding its operations and interactions with stakeholders.

• Core Areas: Respiratory, Neonatology, Rare Diseases
• Global Presence: Operations in over 30 countries
• Commitment to R&D: Significant investment in innovative therapies
• Sustainability Focus: Minimizing environmental impact and promoting community health

With a dedicated workforce and a passion for innovation, Chiesi Group continues to make strides in the pharmaceutical industry, aiming to be a leader in providing effective healthcare solutions.